These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding. Daenke S, Schramm HJ, Bangham CR. J Gen Virol; 1994 Sep; 75 ( Pt 9)():2233-9. PubMed ID: 8077922 [Abstract] [Full Text] [Related]
17. Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor. Priestle JP, Fässler A, Rösel J, Tintelnot-Blomley M, Strop P, Grütter MG. Structure; 1995 Apr 15; 3(4):381-9. PubMed ID: 7613867 [Abstract] [Full Text] [Related]
18. Substrates and inhibitors of human T-cell leukemia virus type I protease. Ding YS, Rich DH, Ikeda RA. Biochemistry; 1998 Dec 15; 37(50):17514-8. PubMed ID: 9860866 [Abstract] [Full Text] [Related]
19. Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases. Lin YC, Beck Z, Morris GM, Olson AJ, Elder JH. J Virol; 2003 Jun 15; 77(12):6589-600. PubMed ID: 12767979 [Abstract] [Full Text] [Related]